Merck (MRK) Fundamental Analysis: Revenue, Earnings & Valuation

5.79 / 10

Netural

Fundamental rating is Neutral (5.8/10). Strengths include low Days Sales Outstanding (61) and favorable Cost‑of‑Sales ratio (25%). Weak points are modest YoY revenue growth (1.3%) and negative Asset‑MV (-0.55). Overall fundamentals are modest but not alarming.

Analysis Checks(8/10)

Total operating revenue (YoY growth rate %)

Value1.31

Score1/3

Weight-2.92%

1M Return-1.58%

Days sales outstanding

Value61.06

Score3/3

Weight-0.30%

1M Return-0.15%

Profit-MV

Value1.49

Score3/3

Weight20.60%

1M Return7.65%

Net income-Revenue

Value0.78

Score3/3

Weight21.91%

1M Return7.98%

PB-ROE

Value0.87

Score2/3

Weight13.95%

1M Return5.86%

Cash-UP

Value-0.83

Score3/3

Weight22.50%

1M Return7.32%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.26

Score2/3

Weight-2.56%

1M Return-1.40%

Cost of sales ratio (%)

Value25.20

Score3/3

Weight2.08%

1M Return0.98%

Asset-MV

Value-0.55

Score1/3

Weight15.39%

1M Return5.66%

Cash-MV

Value-0.25

Score2/3

Weight9.34%

1M Return4.33%

Is MRK fundamentally strong?

MRK scores 5.79/10 on fundamentals and holds a Fair valuation at present. Backed by its 36.86% ROE, 28.09% net margin, 16.11 P/E ratio, 5.58 P/B ratio, and 7.99% earnings growth, these metrics solidify its Netural investment rating.